Edition:
United States

Virbac SA (VIRB.PA)

VIRB.PA on Paris Stock Exchange

176.60EUR
25 Jul 2016
Change (% chg)

-- (--)
Prev Close
€176.60
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
7,978
52-wk High
€224.00
52-wk Low
€144.10

VIRB.PA

Chart for VIRB.PA

About

Virbac SA is a France-based veterinarian pharmaceutical company that specializes in the development and production of vaccines and medicines for domestic animals and livestock. Its production centers are located in France, Australia, the United States, Mexico, Vietnam, Brazil and South Africa. Its development efforts focus... (more)

Overall

Beta: 0.67
Market Cap(Mil.): €1,476.77
Shares Outstanding(Mil.): 8.46
Dividend: --
Yield (%): --

Financials

  VIRB.PA Industry Sector
P/E (TTM): 156.60 36.15 37.05
EPS (TTM): 1.11 -- --
ROI: 1.55 15.11 14.35
ROE: 2.16 16.17 15.56

BRIEF-Virbac Q2 revenue up at 218.6 mln euros

* Reports Q2 revenue of 218.6 million euros ($242.1 million) versus 220.9 million euros a year ago

Jul 18 2016

BRIEF-Virbac Q1 sales stable at 211.4 million euros

* Q1 sales at 211.4 million euros ($238.50 million), stable compared to year ago Source text for Eikon: Further company coverage: ($1 = 0.8864 euros) (Gdynia Newsroom)

Apr 13 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Reuters Investment Profile
$20.00
Provider : Wright Reports
$75.00
Provider : Sadif Analytics Prime
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.